MedPath

Pragmatic Cluster Randomised Controlled Trial of the Practical Approach to Lung Health and Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) in South Africa (PALSA PLUS) Educational Outreach Interventio

Completed
Conditions
HIV/AIDS, Tuberculosis (TB), and STIs.
Infections and Infestations
Registration Number
ISRCTN24820584
Lead Sponsor
niversity of Cape Town Lung Institute (South Africa)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

Clusters: primary care clinics participating in the first phases of the rollout of the national AntiRetroviral Treatment (ART) programme in the Free State province, South Africa
Patients: All patients enrolled in the national ART programme at these clinics

PALSA PLUS Western Cape trial:
In addition to the above inclusion criteria, the PALSA PLUS Western Cape trial will also include primary care facilities where care for HIV and TB is provided.
Patients: all patients 15 years or older attending these facilities for the trial duration (36 weeks).

Exclusion Criteria

None

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath